These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22984596)

  • 21. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
    Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J
    Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones.
    Arabiyat S; Kasabri V; Al-Hiari Y; Al-Masri I; Alalawi S; Bustanji Y
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2503-2514. PubMed ID: 31450926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
    Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
    Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.
    Li S; Xu H; Cui S; Wu F; Zhang Y; Su M; Gong Y; Qiu S; Jiao Q; Qin C; Shan J; Zhang M; Wang J; Yin Q; Xu M; Liu X; Wang R; Zhu L; Li J; Xu Y; Jiang H; Zhao Z; Li J; Li H
    J Med Chem; 2016 Jul; 59(14):6772-90. PubMed ID: 27396490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ephedrine as a lead compound for the development of new DPP-IV inhibitors.
    Ojeda-Montes MJ; Ardid-Ruiz A; Tomás-Hernández S; Gimeno A; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Garcia-Vallvé S; Pujadas G; Valls C
    Future Med Chem; 2017 Dec; 9(18):2129-2146. PubMed ID: 29172693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study.
    Almasri IM; Taha MO; Mohammad MK
    Arch Pharm Res; 2013 Nov; 36(11):1326-37. PubMed ID: 23918649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
    Deng X; Han L; Zhou J; Zhang H; Li Q
    Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of anthraquinones as DPP-IV inhibitors: Structure-activity relationships and inhibitory mechanism.
    Ma HH; Zhang J; Li CQ; Zou LW
    Fitoterapia; 2023 Jul; 168():105549. PubMed ID: 37244503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
    Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
    Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
    Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mining large databases to find new leads with low similarity to known actives: application to find new DPP-IV inhibitors.
    Ojeda-Montes MJ; Casanova-Martí À; Gimeno A; Tomás-Hernández S; Cereto-Massagué A; Wolber G; Beltrán-Debón R; Valls C; Mulero M; Pinent M; Pujadas G; Garcia-Vallvé S
    Future Med Chem; 2019 Jun; 11(12):1387-1401. PubMed ID: 31298576
    [No Abstract]   [Full Text] [Related]  

  • 33. Separation, identification and molecular binding mechanism of dipeptidyl peptidase IV inhibitory peptides derived from walnut (Juglans regia L.) protein.
    Kong X; Zhang L; Song W; Zhang C; Hua Y; Chen Y; Li X
    Food Chem; 2021 Jun; 347():129062. PubMed ID: 33476918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
    Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
    Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor.
    Nojima H; Kanou K; Terashi G; Takeda-Shitaka M; Inoue G; Atsuda K; Itoh C; Iguchi C; Matsubara H
    BMC Struct Biol; 2016 Aug; 16():11. PubMed ID: 27491540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.
    Jiang YK
    J Mol Model; 2010 Jul; 16(7):1239-49. PubMed ID: 20069322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides in camel milk protein hydrolysates.
    Nongonierma AB; Paolella S; Mudgil P; Maqsood S; FitzGerald RJ
    Food Chem; 2018 Apr; 244():340-348. PubMed ID: 29120791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of
    Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M; Gupta M; Singh D; Kumar M; Kaur P
    Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
    Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.